Fortis Group Advisors LLC Has $5.98 Million Stock Holdings in Hims & Hers Health, Inc. $HIMS

Fortis Group Advisors LLC lifted its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS) by 87.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 105,335 shares of the company’s stock after acquiring an additional 49,205 shares during the period. Hims & Hers Health makes up about 1.0% of Fortis Group Advisors LLC’s investment portfolio, making the stock its 20th biggest position. Fortis Group Advisors LLC’s holdings in Hims & Hers Health were worth $5,975,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HIMS. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of Hims & Hers Health by 0.8% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 25,600 shares of the company’s stock valued at $1,452,000 after purchasing an additional 200 shares during the period. GAMMA Investing LLC increased its holdings in shares of Hims & Hers Health by 6.1% during the third quarter. GAMMA Investing LLC now owns 4,098 shares of the company’s stock worth $232,000 after buying an additional 236 shares in the last quarter. Concurrent Investment Advisors LLC raised its stake in shares of Hims & Hers Health by 1.8% in the third quarter. Concurrent Investment Advisors LLC now owns 13,984 shares of the company’s stock valued at $793,000 after acquiring an additional 252 shares during the last quarter. Smartleaf Asset Management LLC grew its position in Hims & Hers Health by 44.7% during the 3rd quarter. Smartleaf Asset Management LLC now owns 916 shares of the company’s stock worth $54,000 after acquiring an additional 283 shares during the last quarter. Finally, Bessemer Group Inc. raised its position in Hims & Hers Health by 105.8% in the 2nd quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after purchasing an additional 312 shares during the last quarter. Institutional investors own 63.52% of the company’s stock.

Insider Activity at Hims & Hers Health

In related news, insider Deborah M. Autor sold 7,054 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $36.71, for a total transaction of $258,952.34. Following the completion of the transaction, the insider owned 6,175 shares in the company, valued at approximately $226,684.25. The trade was a 53.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Irene Becklund sold 8,411 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The shares were sold at an average price of $36.71, for a total transaction of $308,767.81. Following the completion of the sale, the insider directly owned 2,126 shares of the company’s stock, valued at $78,045.46. The trade was a 79.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 82,963 shares of company stock worth $2,944,621. 17.71% of the stock is owned by company insiders.

Hims & Hers Health Stock Up 0.1%

Shares of Hims & Hers Health stock opened at $16.31 on Wednesday. The business has a fifty day simple moving average of $29.94 and a 200 day simple moving average of $41.14. The stock has a market cap of $3.71 billion, a PE ratio of 30.20, a price-to-earnings-growth ratio of 3.04 and a beta of 2.43. The company has a quick ratio of 1.64, a current ratio of 1.88 and a debt-to-equity ratio of 1.67. Hims & Hers Health, Inc. has a 12 month low of $15.63 and a 12 month high of $72.98.

Hims & Hers Health declared that its board has authorized a stock buyback program on Monday, November 17th that allows the company to buyback $250.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Analysts Set New Price Targets

Several brokerages have recently commented on HIMS. BTIG Research decreased their target price on Hims & Hers Health from $85.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft set a $31.00 price objective on shares of Hims & Hers Health and gave the stock a “hold” rating in a report on Tuesday, February 10th. Zacks Research downgraded shares of Hims & Hers Health from a “hold” rating to a “strong sell” rating in a research note on Monday, January 19th. Bank of America reduced their target price on shares of Hims & Hers Health from $26.00 to $21.00 and set an “underperform” rating on the stock in a research report on Monday, February 9th. Finally, TD Cowen dropped their price objective on shares of Hims & Hers Health from $30.00 to $20.00 and set a “hold” rating for the company in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, nine have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $39.32.

Hims & Hers Health Profile

Hims & Hers Health, Inc is a telehealth platform providing direct-to-consumer personal care products and virtual medical services in the United States. Operating under the Hims & Hers brand, the company offers an integrated digital experience that connects users with licensed healthcare providers, enabling online consultations and prescriptions for a range of conditions. Its telemedicine infrastructure supports both prescription medications and over-the-counter products, with home delivery to patients’ doorsteps.

The company’s product portfolio addresses key areas of men’s and women’s health, including hair loss treatments, sexual wellness therapies, skincare regimens and mental health support.